http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2011027893-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-707 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2011027893-A1 |
| titleOfInvention | Method for predicting therapeutic effect of chronic hepatitis C |
| abstract | A method for predicting the therapeutic effect of peginterferon and ribavirin combination therapy in the treatment of chronic hepatitis C, A drug sensitivity marker detection step of detecting a drug sensitivity marker in a biological sample, and a drug sensitivity evaluation step of evaluating the drug sensitivity of the biological sample based on the expression level of the drug sensitivity marker, The biological sample is a liver-derived cell or tissue; The method, wherein the drug sensitivity marker comprises at least one microRNA selected from the group consisting of the microRNAs shown in SEQ ID NOs: 1 to 37. |
| priorityDate | 2009-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.